Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Multiple Sclerosis Epidemiology

Early Signs of Multiple Sclerosis

Multiple sclerosis and beta interferon

Primary Progressive Multiple Sclerosis (PPMS)

Secondary Progressive Multiple Sclerosis (SPMS)

Benign Multiple Sclerosis (MS)

See more featured articles »

Types of Multiple Sclerosis (MS)

Multiple Sclerosis and Pregnancy

Multiple Sclerosis in Children

At-Home Physiotherapy Exercises for Multiple Sclerosis

Epigenetics for Multiple Sclerosis

Anti-Myelin Antibodies in Multiple Sclerosis

Cognitive Impairment and Multiple Sclerosis

Remyelination Strategies for Multiple Sclerosis

Heat Intolerance in Multiple Sclerosis

Multiple sclerosis and smoking

Optic Neuritis and Multiple Sclerosis

How is RRMS Different from PPMS and SPMS?

Relapsing-Remitting Multiple Sclerosis (RRMS)

Latest Multiple Sclerosis News and Research

Researchers develop a potential treatment approach for Pelizaeus-Merzbacher disease

A team led by Case Western Reserve University medical researchers has developed a potential treatment method for Pelizaeus-Merzbacher disease (PMD), a fatal neurological disorder that produces severe movement, motor and cognitive dysfunction in children.

1 Jul 2020

Novel brain pathology could improve diagnosis, treatment of neurodegenerative diseases

Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington's disease.

30 Jun 2020

SAFB1 may be a diagnostic marker for neurodegenerative diseases, shows study

Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington's disease.

30 Jun 2020

Majority of people with MS use complementary and alternative medicine, survey finds

A new survey of more than 1,000 people with multiple sclerosis finds that an overwhelming majority use complementary and alternative medicine, with many using cannabis.

25 Jun 2020

U.K. to roll out the largest genetic study on chronic fatigue syndrome

Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.

24 Jun 2020

Parasitic worms could offer new treatment hope for MS patients

Parasitic worms could offer a new treatment hope for patients suffering from the autoimmune disease multiple sclerosis, according to experts from the University of Nottingham.

18 Jun 2020

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Researchers at Kessler Foundation conducted a comprehensive review of pharmacologic agents used in the treatment of multiple sclerosis, seeking evidence for efficacy for the cognitive dysfunction experienced by more than half of affected individuals.

17 Jun 2020

Experts evaluate options for treating cognitive deficits in multiple sclerosis

Experts in cognitive research evaluated the status of available treatments as well as promising strategies for treating cognitive deficits in multiple sclerosis.

16 Jun 2020

Common cholesterol-lowering drug linked to improvement in gut microbiota

There is a clear link between improved gut microbiota and one of our most common cholesterol-lowering drug groups: statins.

15 Jun 2020

Case series: COVID-19 in teriflunomide-treated patients with MS

During the COVID-19 pandemic, patients with multiple sclerosis (MS) and their clinicians have had questions and concerns about whether immunotherapies for MS could influence risk for infection or lead to an unfavorable outcome.

12 Jun 2020

Experts clarify MS subtypes to improve care and access to treatments

An international committee of multiple sclerosis (MS) experts has clarified their previously published descriptors of the different courses of MS and disease activity.

11 Jun 2020

Examining dopamine receptors in their natural environment

Dopamine, a chemical that sends messages between different parts of the brain and body, plays a key role in a variety of diseases and behaviors by interacting with receptors on cells.

11 Jun 2020

“Shouting" and spelling errors make online health information doubly less trustworthy

People make irrational trust decisions precisely: "shouting" and spelling mistakes add together to make online health information appear doubly less trustworthy.

11 Jun 2020

Cleveland Clinic receives $7.2 million to improve accuracy of MS diagnoses

The National Institutes of Health has awarded $7.2 million to a Cleveland Clinic-led research team to improve accuracy of multiple sclerosis (MS) diagnoses.

10 Jun 2020

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

A new study from Lawson Health Research Institute and Western University suggests that fecal transplants could be used as a treatment for non-alcoholic fatty liver disease.

9 Jun 2020

Immune system can be re-wired to prevent attack of healthy cells, study finds

The body's immune system can be re-wired to prevent it from recognizing its own proteins which, when attacked by the body, can cause autoimmune diseases like multiple sclerosis, a significant new study by UK scientists has found.

9 Jun 2020

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Dr. Leszek Ignatowicz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $1.95 million federal grant to study what causes autoimmunity in the human body.

8 Jun 2020

Study uncovers link between psoriasis and joint disease

A team led by Case Western Reserve University School of Medicine researchers has made two major discoveries involving psoriasis, a chronic and debilitating skin disease with no known cure.

8 Jun 2020

New digital tool to support mental health of MS patients developed with UK HCPs

Biogen Inc. today announced the launch of a free, new, digital self-help tool to help people living with multiple sclerosis (MS) navigate the emotional challenges of life with the disease. The tool, named ACT MySelf, was developed by Biogen in collaboration with people living with MS, the MS Trust, a team of MS specialist nurses and an MS clinical psychologist.

5 Jun 2020

New technology to monitor anti-drug antibodies in MS patients may have potential for COVID-19 testing

A new study led by Queen Mary University of London has demonstrated the effectiveness of using a novel light technology to monitor the presence of anti-drug antibodies in the treatment of multiple sclerosis, which can lead to drug resistance and treatment failure.

4 Jun 2020